Optimal biological dose: a systematic review in cancer phase I clinical trials by J. Fraisse, D. Dinart, D. Tosi, C. Bellera, C. Mollevi

Get full text

Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5... by B. Cuer, C. Mollevi, A. Anota, E. Charton, B. Juzyna, T. Conroy, C. Touraine

Get full text

GUIP1: a R package for dose escalation strategies in phase I cancer clinical trials by D. Dinart, J. Fraisse, D. Tosi, A. Mauguen, C. Touraine, S. Gourgou, M. C. Le Deley, C. Bellera, C. Mollevi

Get full text

Antibody targeting of claudin-1 as a potential colorectal cancer therapy by S. Cherradi, A. Ayrolles-Torro, N. Vezzo-Vié, N. Gueguinou, V. Denis, E. Combes, F. Boissière, M. Busson, L. Canterel-Thouennon, C. Mollevi, M. Pugnière, F. Bibeau, M. Ychou, P. Martineau, C. Gongora, M. Del Rio

Get full text